Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Vamikibart shows sustained one-year vision improvements in Phase III uveitic macular edema studies


Regeneron to present new Libtayo and cancer-associated thrombosis data at ESMO 2026


FDA accepts Bayer application for finerenone in chronic kidney disease without diabetes


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Risk Assessment of Extractables and Leachables in Different Phases of Development.

Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals and Ward d’Autry, Study Director E/L & Structural Elucidation, Nelson Labs Europe
22nd April 2021


The Business Benefits of PAT in Continuous Drug Product Manufacturing

Presented by Steve Hammond, Independent Consultant at Steve Hammond Consulting
22nd September 2021


Meaningful Metrics For The Microbiology Laboratory

Presented by Karen McCullough, Principal Consultant at MMI Associates
29th October 2014


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia